Tanga W, Liua W, Li HM, et al. - Forty people with histologically verified pancreatic ductal carcinoma (PDC) who underwent quantitative dynamic contrast-enhanced (DCE)-MRI were retrospectively investigated in order to examine the role of the quantitative parameters of DCE-MRI in the prognostication of the response to chemotherapy in PDC. All individuals were categorized into groups of responders and nonresponders. It was discovered that in individuals with PDC, quantitative parameters derived from DCE-MRI could be a possible predictor of response to gemcitabine. Moreover, perfusion parameters were diverse depending on the site of the region of interest on various tumoral and peritumoral areas.